Thursday, February 12th, 2004 - ERBITUX–Cetuximab–Receives FDA Approval to Treat Irinotecan Refractory or Intolerant Metastatic Colorectal Cancer; First-of-its-Kind Antibody Approved for Use in Combination with Irinotecan and As a Single Agent

Main:
Home | Contact The Mesothelioma Center
Asbestos Diseases:
Malignant Mesothelioma: Pleural, Peritoneal | Diagnosis | Symptoms | Treatment Options | Clinical Trials | Asbestos Lung Cancer | Asbestosis
Asbestos:
About Asbestos | Asbestos in Materials | Products that contain Asbestos
Hope & Help:
Support | Patient Network | Support Groups | Doctors/Specialists
Info & Resources:
Looking for mesothelioma lawyers? Experienced asbestos attorneys.
Please read our disclaimer. Goldberg, Persky & White, P.C.
Last Updated: January 13, 2012. 06:25:40 pm.